These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1044 related articles for article (PubMed ID: 27353189)

  • 41. Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.
    le Roux SM; Abrams EJ; Donald KA; Brittain K; Phillips TK; Nguyen KK; Zerbe A; Kroon M; Myer L
    Lancet Child Adolesc Health; 2019 Apr; 3(4):234-244. PubMed ID: 30773459
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disengagement of HIV-positive pregnant and postpartum women from antiretroviral therapy services: a cohort study.
    Phillips T; Thebus E; Bekker LG; Mcintyre J; Abrams EJ; Myer L
    J Int AIDS Soc; 2014; 17(1):19242. PubMed ID: 25301494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Linkage to care, mobility and retention of HIV-positive postpartum women in antiretroviral therapy services in South Africa.
    Phillips TK; Clouse K; Zerbe A; Orrell C; Abrams EJ; Myer L
    J Int AIDS Soc; 2018 Jul; 21 Suppl 4(Suppl Suppl 4):e25114. PubMed ID: 30027583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maternal HIV-1 DNA load and mother-to-child transmission.
    Arvold ND; Ngo-Giang-Huong N; McIntosh K; Suraseranivong V; Warachit B; Piyaworawong S; Changchit T; Lallemant M; Jourdain G;
    AIDS Patient Care STDS; 2007 Sep; 21(9):638-43. PubMed ID: 17919090
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
    Ciaranello AL; Seage GR; Freedberg KA; Weinstein MC; Lockman S; Walensky RP
    AIDS; 2008 Nov; 22(17):2359-69. PubMed ID: 18981776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of plasma viral-load monitoring and the prevention of mother-to-child transmission of HIV-1 in three health facilities of the Littoral region of Cameroon.
    Kafack EVF; Fokam J; Nana TN; Saniotis A; Halle-Ekane GE
    PLoS One; 2022; 17(11):e0277271. PubMed ID: 36342923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Factors associated with virological response in women receiving highly-active antiretroviral prophylaxis for HIV-1 mother-to-child transmission].
    Palacios R; Senise JF; Vaz MJ; Castelo A
    Enferm Infecc Microbiol Clin; 2008; 26(7):411-5. PubMed ID: 18842235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV Viremia During Pregnancy and Neurodevelopment of HIV-Exposed Uninfected Children in the Context of Universal Antiretroviral Therapy and Breastfeeding: A Prospective Study.
    le Roux SM; Donald KA; Kroon M; Phillips TK; Lesosky M; Esterhuyse L; Zerbe A; Brittain K; Abrams EJ; Myer L
    Pediatr Infect Dis J; 2019 Jan; 38(1):70-75. PubMed ID: 30234792
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 90-90-90 cascade analysis on reported CLHIV infected by mother-to-child transmission in Guangxi, China: a modeling study.
    Wang G; Lu C; Qin S; Wei W; Lai J; Jiang J; Liang B; Zhou O; Han J; Yang Y; Ye L; Liang H; Ning C
    Sci Rep; 2020 Mar; 10(1):5295. PubMed ID: 32210333
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Why are HIV-infected infants still being born in Spain?].
    Fernández-Ibieta M; Ramos Amador JT; Guillén Martín S; González-Tomé MI; Navarro Gómez M; Iglesias González-Nicolás E; Rubio Gribble B; de José Gómez MI; Beceiro Mosquera J; Regidor J; De Santos Butragueño MJ; Martínez Guardia N; Roa Francia MA
    An Pediatr (Barc); 2007 Aug; 67(2):109-15. PubMed ID: 17692255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.
    Warszawski J; Tubiana R; Le Chenadec J; Blanche S; Teglas JP; Dollfus C; Faye A; Burgard M; Rouzioux C; Mandelbrot L;
    AIDS; 2008 Jan; 22(2):289-99. PubMed ID: 18097232
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission.
    Landes M; van Lettow M; van Oosterhout JJ; Schouten E; Auld A; Kalua T; Jahn A; Tippett Barr BA
    PLoS One; 2021; 16(3):e0248559. PubMed ID: 33711066
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viral suppression and factors associated with failure to achieve viral suppression among pregnant women in South Africa.
    Woldesenbet SA; Kufa T; Barron P; Chirombo BC; Cheyip M; Ayalew K; Lombard C; Manda S; Diallo K; Pillay Y; Puren AJ
    AIDS; 2020 Mar; 34(4):589-597. PubMed ID: 31821189
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Trends and effects of antiretroviral therapy coverage during pregnancy on mother-to-child transmission of HIV in Sub-Saharan Africa. Evidence from panel data analysis.
    Astawesegn FH; Stulz V; Conroy E; Mannan H
    BMC Infect Dis; 2022 Feb; 22(1):134. PubMed ID: 35135474
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Towards elimination of mother-to-child transmission of HIV in Rwanda: a nested case-control study of risk factors for transmission.
    Remera E; Mugwaneza P; Chammartin F; Mulindabigwi A; Musengimana G; Forrest JI; Mwanyumba F; Kondwani N; Condo JU; Riedel DJ; Mills EJ; Nsanzimana S; Bucher HC
    BMC Pregnancy Childbirth; 2021 Apr; 21(1):339. PubMed ID: 33910502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevention of mother-to-child transmission of HIV in rural Uganda: modelling effectiveness and impact of scaling-up PMTCT services.
    Larsson EC; Ekström AM; Pariyo G; Tomson G; Sarowar M; Baluka R; Galiwango E; Thorson AE
    Glob Health Action; 2015; 8():26308. PubMed ID: 25726836
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Selph SS; Bougatsos C; Dana T; Grusing S; Chou R
    JAMA; 2019 Jun; 321(23):2349-2360. PubMed ID: 31184704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Timing of pregnancy, postpartum risk of virologic failure and loss to follow-up among HIV-positive women.
    Onoya D; Sineke T; Brennan AT; Long L; Fox MP
    AIDS; 2017 Jul; 31(11):1593-1602. PubMed ID: 28463877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detectable Viral Load in Late Pregnancy among Women in the Rwanda Option B+ PMTCT Program: Enrollment Results from the Kabeho Study.
    Gill MM; Hoffman HJ; Bobrow EA; Mugwaneza P; Ndatimana D; Ndayisaba GF; Baribwira C; Guay L; Asiimwe A
    PLoS One; 2016; 11(12):e0168671. PubMed ID: 28006001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.